Cleared Traditional

K770705 - CARDIAC ACQUISITION SYSTEM, ICR 2001

K770705 is an FDA 510(k) clearance for CARDIAC ACQUISITION SYSTEM, manufactured by Instruments For Cardiac Research. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 45-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1977
Decision
45d
Days
Class 2
Risk

K770705 is an FDA 510(k) clearance for the CARDIAC ACQUISITION SYSTEM, ICR 2001. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Instruments For Cardiac Research (Mchenry, US). The FDA issued a Cleared decision on June 2, 1977 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K770705

510(k) Number K770705 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 1977
Decision Date June 02, 1977
Days to Decision 45 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 125d · This submission: 45d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 440
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K770705.
CLINICAL GRAPHICS ANALYZER
K780468 · Numonics Corp. · Jun 1978
MODEL 5621A INTERFACE
K780768 · Hewlett-Packard Co. · May 1978
AUTOMATED PHYSIOLOGIC PROFILER
K780530 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1978
MEDDARS CARDIOVASCULAR DIAGNOSTIC SYSTEM
K760767 · Honeywell, Inc. · Oct 1976